Kin L. Wong

Usefulness of resistant gene markers for predicting treatment outcome on second‐line anti‐tuberculosis drugs

M. Y. Chan, K. L. Leung, W. Y. Chan, 2010, Journal of applied microbiology.

SM03, an Anti-CD22 Antibody, Converts Cis-to-Trans Ligand Binding of CD22 against α2,6-Linked Sialic Acid Glycans and Immunomodulates Systemic Autoimmune Diseases

Nan Song, S. Leung, Zhengdong Li, 2022, The Journal of Immunology.